Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Sep;22(3):301–308. doi: 10.1111/j.1365-2125.1986.tb02891.x

Pharmacodynamics and pharmacokinetics of single doses of ketanserin and propranolol alone and in combination in healthy volunteers.

F M Williams, J E Leeser, M D Rawlins
PMCID: PMC1401118  PMID: 3768242

Abstract

The potential interaction between ketanserin and propranolol has been investigated in eight healthy volunteers. Volunteers received single doses of placebo, propranolol (80 mg), ketanserin (20 mg), and propranolol (80 mg) plus ketanserin (20 mg) following a randomised double-blind regimen. A single dose of ketanserin had little effect on resting heart rate and blood pressure and the effects of propranolol and ketanserin in combination were similar to those of propranolol alone. The inhibition of exercise induced tachycardia by propranolol was not affected by ketanserin. The pharmacokinetics of propranolol elimination were not influenced by the concurrent administration of ketanserin, nor the pharmacokinetics of ketanserin by propranolol.

Full text

PDF
301

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amery A., Fagard R., Fiocchi R., Lijnen P., Staessen J., Vanhees L. Ketanserin: a new hypotensive drug? J Cardiovasc Pharmacol. 1985;7 (Suppl 7):S176–S182. [PubMed] [Google Scholar]
  2. Elliott H. L., McLean K., Sumner D. J., Meredith P. A., Reid J. L. Immediate cardiovascular responses to oral prazosin--effects of concurrent beta-blockers. Clin Pharmacol Ther. 1981 Mar;29(3):303–309. doi: 10.1038/clpt.1981.40. [DOI] [PubMed] [Google Scholar]
  3. Fagard R., Cattaert A., Lijnen P., Staessen J., Vanhees L., Moerman E., Amery A. Responses of the systemic circulation and of the renin-angiotensin-aldosterone system to ketanserin at rest and exercise in normal man. Clin Sci (Lond) 1984 Jan;66(1):17–25. doi: 10.1042/cs0660017. [DOI] [PubMed] [Google Scholar]
  4. Hedner T., Persson B. Antihypertensive properties of ketanserin in combination with beta-adrenergic blocking agents. J Cardiovasc Pharmacol. 1985;7 (Suppl 7):S161–S163. doi: 10.1097/00005344-198500077-00045. [DOI] [PubMed] [Google Scholar]
  5. Hedner T., Persson B., Berglund G. Ketanserin, a novel 5-hydroxytryptamine antagonist: monotherapy in essential hypertension. Br J Clin Pharmacol. 1983 Aug;16(2):121–125. doi: 10.1111/j.1365-2125.1983.tb04974.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lo M. W., Silber B., Riegelman S. An automated HPLC method for the assay of propranolol and its basic metabolites in plasma and urine. J Chromatogr Sci. 1982 Mar;20(3):126–131. doi: 10.1093/chromsci/20.3.126. [DOI] [PubMed] [Google Scholar]
  7. Park B. K. Prediction of metabolic drug interactions involving beta-adrenoceptor blocking drugs. Br J Clin Pharmacol. 1984;17 (Suppl 1):3S–10S. doi: 10.1111/j.1365-2125.1984.tb02422.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Reimann I. W., Frölich J. C. Mechanism of antihypertensive action of ketanserin in man. Br Med J (Clin Res Ed) 1983 Aug 6;287(6389):381–383. doi: 10.1136/bmj.287.6389.381-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Zoccali C., Zabludowski J. R., Isles C. G., Murray G. D., Inglis G. C., Robertson J. I., Fraser R., Ball S. G. The effect of a 5-HT antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympathoadrenal function in normal man. Br J Clin Pharmacol. 1983 Sep;16(3):305–311. doi: 10.1111/j.1365-2125.1983.tb02166.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES